Analyst consensus rating
TuHURA Biosciences Analyst Rating: Strong Buy
Direct answer
TuHURA Biosciences's consensus rating is Strong Buy.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.04.
Forecast evidence checked October 2, 2026.
Get free TuHURA Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.90
- Average price target
- $8.04
- High price target
- $10.00
- Low price target
- $6.20
- Low target gap
- +225.5%
- Target upside
- +322.1%
- High target gap
- +425%
- Target range width
- 199.5%
- Consensus rating
- Strong Buy
- Analysts
- 5
- Evidence date
- October 2, 2026
- Valid through
- October 9, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for TuHURA Biosciences?
TuHURA Biosciences has a verified Strong Buy consensus. The same dataset has an average price target of $8.04.
How far are TuHURA Biosciences's low and high targets from the recorded price?
The low target implies +225.5%, while the high target implies +425%.
How many analysts are included in TuHURA Biosciences's consensus?
The verified consensus includes 5 analysts.
How is TuHURA Biosciences's target upside or downside calculated?
The average target of $8.04 is divided by the recorded price of $1.90, then one is subtracted to produce +322.1%. This does not guarantee a future return.
When was TuHURA Biosciences's analyst forecast verified?
The data was verified on 2026-10-02. The dataset is valid through 2026-10-09.